HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Generation of a human induced pluripotent stem cell line (NCCDFWi001-A) from a Marfan syndrome patient carrying two FBN1 variants (c.2613A > C and c.684_736 + 4del).

Abstract
The human induced pluripotent stem cell line NCCDFWi001-A was derived from peripheral blood mononuclear cells (PBMC) of a 26-year-old female Marfan syndrome patient carrying two compound heterozygous variants FBN1c.2613A > C, (p.Leu871Phe) and c.684_736 + 4del. The established patient-derived iPSC showed expression of pluripotent stem cell markers and had the ability to differentiate into all of the three germ layers and possessed a normal karyotype.
AuthorsBaihui Ma, Mingyao Luo, Hang Yang, Tianjiao Li, Weiwei Liu, Faxiang Xu, Chang Shu, Guokai Chen, Zhou Zhou
JournalStem cell research (Stem Cell Res) Vol. 42 Pg. 101690 (01 2020) ISSN: 1876-7753 [Electronic] England
PMID31901832 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2019 ational Center for Cardiovascular Diseases & Fuwai Hospital. Published by Elsevier B.V. All rights reserved.
Chemical References
  • FBN1 protein, human
  • Fibrillin-1
Topics
  • Adult
  • Animals
  • Cell Line
  • Female
  • Fibrillin-1 (genetics)
  • Humans
  • Induced Pluripotent Stem Cells (metabolism)
  • Marfan Syndrome (genetics)
  • Mutation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: